BOOK REVIEWS By: Tracy Batchelor, Ryo Nishikawa, Nancy Tarbell, Michael Weller, editors Published by: Oxford University Press, New York, New York, 2017 Hardcover: 272 pp. Price: $150.00 ISBN: 9780199651870 Oncology is one of the most rapidly advancing fields in medicine as molecular biology and genetics have increased our understanding of tumor pathophysiology. The 2016 World Health Organization (WHO) update marks a change in histologic classification with the addition of genetic profiling. As we enter this new era, there is a need for books like this that better elucidate these guidelines and map out a new landscape of diagnosis and treatment options. Intended for neurologists, neurosurgeons, and neuro-oncologists, this book is for anyone looking to advance their practice to match the latest guidelines, while also keeping an eye on new developments. In this concise yet comprehensive reference, each tumor entity in the updated classification is treated with its own chapter reviewing the epidemiology, risk factors, imaging, histology, and treatment options. Not simply a catalog of the literature, each chapter focuses on studies that have shaped our understanding and standard of care. The text starts with a quick summary of the advances in The text touches on every major subtype in the 2016 WHO genetics leading to the WHO 2016 changes. The first table classification with excellent chapters on the more common astro- summarizes this new taxonomy. For glioblastoma, IDH mutant cytic, oligodendroglial, and meningeal tumors, but also provides and wild-type classification is now the standard of care for superb coverage to less common ependymal, choroidal, and diagnosis. The second table outlines the differences in treatment pineal tumors, along with everything in between. Each chapter and prognosis. Importantly, it discusses classifications made is roughly 8 to 10 pages with 50 to 100 references for the inter- obsolete, such as “oligoastrocytoma.” ested reader, while the entire text is just under 250 pages. Each subsequent chapter reviews a tumor entity or Overall, I highly recommend this text. It is a concise yet grouping. For example, for the chapter on meningiomas complete reference for clinicians wishing to review the latest after reviewing epidemiology, pathological classification, and diagnosis and treatment options. surgical management, the chapter goes into multiple options Disclosure for radiation therapy. It touches on fractionated external beam, radiosurgery, and proton therapy, while discussing important The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article. studies, recurrence rates, and complications. Also included is a review of studies examining chemotherapy, hormonal receptors, James G Malcolm, MD, PhD targeted molecular agents, platelet-derived growth factor, and Vijay Agarwal, MD anti-angiogenesis agents. The chapter does an excellent job Department of Neurosurgery summarizing the literature with references for the reader. This Emory University and other chapters provide clinicians with just enough infor- Atlanta, Georgia mation to stay abreast of the latest developments and answer any questions patients may have. For more nuanced diagnoses, 10.1093/neuros/nyy031 several chapters diagram updated treatment algorithms. NEUROSURGERY VOLUME 82 | NUMBER 6 | JUNE 2018 | E147 Downloaded from https://academic.oup.com/neurosurgery/article-abstract/82/6/E147/4922281 by Ed 'DeepDyve' Gillespie user on 20 June 2018
Neurosurgery – Oxford University Press
Published: May 8, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera